Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency

Lead Sponsor:

Dartmouth-Hitchcock Medical Center

Conditions:

Alcohol Dependence

Eligibility:

All Genders

18-64 years

Phase:

PHASE2

Brief Summary

The purpose of the study is to test whether taking two medicines (quetiapine and mirtazapine) is better for helping people to decrease drinking than taking one medicine alone (quetiapine).

Detailed Description

Alcohol dependence is a debilitating illness affecting almost 8 million people annually and for which the current FDA approved medications are only modestly effective in reducing relapse or drinking. ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Age 18-64
  • The subject meets Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for alcohol dependence
  • The subject is seeking treatment for alcohol dependence and desires a reduction or cessation of drinking
  • The subject is able to verbalize understanding of the consent form, able to provide written informed consent, and able to verbalize willingness to complete study procedures?
  • If the subject is female and of child bearing potential, she agrees to use an acceptable method of birth control.
  • The subject is able to take oral medication, willing to adhere to the medication regimen, and willing to return for regular visits.
  • The subject is able to understand written and oral instructions in English and able to complete the questionnaires required by the protocol.
  • The subject has a breath alcohol concentration (BAC) equal to 0.000 on s/he signing the informed consent document.

Exclusion

    Key Trial Info

    Start Date :

    September 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2012

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT01165541

    Start Date

    September 1 2010

    End Date

    October 1 2012

    Last Update

    April 9 2018

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Dartmouth Medical School Department of Psychiatry's Addition Research Center

    Bedford, New Hampshire, United States, 03110

    2

    Dartmouth Medical School Department of Psychiatry's Addiction Research Center

    Hanover, New Hampshire, United States, 03755